Literature DB >> 7452229

Gangliosides of human cerebral astrocytomas.

T D Traylor, E L Hogan.   

Abstract

Ganglioside content and composition were examined in a series of 25 human gliomas, which were graded histologically by the criteria of Kernohan. The concentration of total gangliosides (lipid-bound sialic acid [LBSA]) was decreased with respect to normal brain tissue in nearly all tumors, and the extent of reduction correlated with the stage of tumor anaplasia. The distribution of individual gangliosides was altered in glial tumor tissue with an increase in proportion of the structurally simple gangliosides and reduction of polysialogangliosides. The most consistent and significant difference was the elevation of proportion of ganglioside GD3 from 4-5% of total LBSA in normal brain to 20% in the astrocytoma grade IV. The proportions of gangliosides GM2 and GD2 were also found to be elevated in all grades of the tumors. The simplification of ganglioside composition seems to be associated with transformation of the astrocyte with the accumulation of the simpler gangliosides, since the changes resemble those reported with in vitro transformation rather than those of analyses of preparations of purified glial cells.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 7452229     DOI: 10.1111/j.1471-4159.1980.tb04630.x

Source DB:  PubMed          Journal:  J Neurochem        ISSN: 0022-3042            Impact factor:   5.372


  18 in total

1.  Plasma membrane-associated glycohydrolases activation by extracellular acidification due to proton exchangers.

Authors:  Massimo Aureli; Nicoletta Loberto; Rosaria Bassi; Anita Ferraretto; Silvia Perego; Patrizia Lanteri; Vanna Chigorno; Sandro Sonnino; Alessandro Prinetti
Journal:  Neurochem Res       Date:  2012-02-23       Impact factor: 3.996

2.  Ganglioside GD3 shedding by human gliomas.

Authors:  O Nakamura; M Iwamori; M Matsutani; K Takakura
Journal:  Acta Neurochir (Wien)       Date:  1991       Impact factor: 2.216

Review 3.  Cancer stem cells in the mammalian central nervous system.

Authors:  G J Pilkington
Journal:  Cell Prolif       Date:  2005-12       Impact factor: 6.831

4.  Stage-specific embryonic antigen-4 as a potential therapeutic target in glioblastoma multiforme and other cancers.

Authors:  Yi-Wei Lou; Pao-Yuan Wang; Shih-Chi Yeh; Po-Kai Chuang; Shiou-Ting Li; Chung-Yi Wu; Kay-Hooi Khoo; Michael Hsiao; Tsui-Ling Hsu; Chi-Huey Wong
Journal:  Proc Natl Acad Sci U S A       Date:  2014-02-03       Impact factor: 11.205

5.  Ganglioside GM3 Is Antiangiogenic in Malignant Brain Cancer.

Authors:  Thomas N Seyfried; Purna Mukherjee
Journal:  J Oncol       Date:  2010-06-20       Impact factor: 4.375

6.  Epidermal growth factor receptor and lipid membrane components in human lung cancers.

Authors:  A Di Carlo; A Mariano; P E Macchia; C Cecere; G Ferrante; V Macchia
Journal:  J Endocrinol Invest       Date:  1993-02       Impact factor: 4.256

7.  Disialoganglioside GD2 in human neuroectodermal tumor cell lines and gliomas.

Authors:  D C Longee; C J Wikstrand; J E Månsson; X He; G N Fuller; S H Bigner; P Fredman; L Svennerholm; D D Bigner
Journal:  Acta Neuropathol       Date:  1991       Impact factor: 17.088

8.  Effects of cell density on the neutral glycolipid composition of cultured human brain and glioma cells.

Authors:  A J Yates; V A Liepkalns; C Icard-Liepkalns; F Jungalwala; R E Stephens; R W Hart
Journal:  Neurochem Res       Date:  1982-10       Impact factor: 3.996

Review 9.  Ganglioside GD3: structure, cellular distribution, and possible function.

Authors:  T N Seyfried; R K Yu
Journal:  Mol Cell Biochem       Date:  1985-09       Impact factor: 3.396

Review 10.  Ganglioside modulation of the PDGF receptor. A model for ganglioside functions.

Authors:  A J Yates; H E Saqr; J Van Brocklyn
Journal:  J Neurooncol       Date:  1995       Impact factor: 4.130

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.